RF
VRTX icon

Rossby Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Rossby Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Sell
228
-28
-11% -$13.1K 0.02% 534
2025
Q4 		$116K Sell
256
-7
-3% -$3.02K 0.04% 376
2025
Q3 		$106K Buy
263
+24
+10% +$10K 0.03% 388
2025
Q2 		$106K Buy
239
+20
+9% +$9.22K 0.04% 350
2025
Q1 		$108K Buy
+219
New +$102K 0.05% 325

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rossby Financial's VRTX Position: Q1 2026 in Review

Rossby Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2026, selling an estimated $13.1K and leaving 228 shares worth $102K. The position accounts for 0.02% of the portfolio, ranked #534.

Rossby Financial first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $116K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Rossby Financial held 228 shares of Vertex Pharmaceuticals worth $102K as of Q1 2026.
  • Rossby Financial sold 28 Vertex Pharmaceuticals shares in Q1 2026, an estimated $13.1K.
  • Vertex Pharmaceuticals made up 0.02% of Rossby Financial's portfolio in Q1 2026, its #534 holding.
  • Rossby Financial first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Rossby Financial's Vertex Pharmaceuticals position peaked at $116K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.